Immune complex deposition is associated with the accumulation of neutrophils, which play an important role in the various immune-mediated diseases. A novel anti-inflammatory agent, the lipoxin A (LXA) analogue (15-epi-16-(FPhO)-LXA-Me)), a stable synthetic analogue of aspirin-triggered 15-epi-lipoxin A4 (ATLa), was used in experimental anti-glomerular basement membrane (GBM) antibody nephritis in mice. ATLa was administered before the induction of the disease, and 2 h later, the animals were killed. ATLa reduced the infiltrating neutrophils and nitrotyrosine staining in glomeruli. Subsequent changes of gene expression in the early phase were evaluated, and 5674 genes were present under the basal conditions in kidneys from normal mice; 54 upregulated genes and 25 downregulated genes were detected in anti-GBM nephritis. Eighteen of these upregulated genes were those induced by IFN-gamma. Real-time quantitative PCR analysis confirmed the results of the microarrays. To investigate a role of IFN-gamma in neutrophil infiltration, anti-GBM nephritis was induced in IFN-gamma knockout mice. The number of infiltrating neutrophils in these mice did not differ from those in wild-type mice. Also examined were CD11b expression on neutrophils from mice treated with ATLa by flow cytometry, but suppression of this adhesion molecule was not observed. Neutrophil infiltration was successfully inhibited by ATLa in the early phase of murine anti-GBM nephritis. Microarray analysis detected the change of mRNA expression in anti-GBM nephritis and demonstrated amelioration of various genes by ATLa, which may provide a clue to the development of novel therapeutic approaches in immune renal injury.

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.asn.0000119962.69573.ccDOI Listing

Publication Analysis

Top Keywords

anti-gbm nephritis
16
anti-glomerular basement
8
basement membrane
8
infiltrating neutrophils
8
early phase
8
upregulated genes
8
induced ifn-gamma
8
neutrophil infiltration
8
neutrophils mice
8
genes
6

Similar Publications

Background: Both intrinsic renal cells and immune cells contribute to driving renal inflammation and damage. However, the respective roles of intrinsic renal cells and immune cells in crescentic glomerulonephritis, and the key molecular factors driving pathogenesis are still unclear.

Methods: The roles of intrinsic renal cells and renal infiltrating immune cells in crescent formation were explored using renal transplantation after experimental anti-GBM disease induction in 129x1/svJ and C57BL/6J mice.

View Article and Find Full Text PDF

Atypical anti-GBM disease in pregnancy.

BMJ Case Rep

November 2024

Kidney Health Service Metronorth, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia.

A woman in her 20s presented with nephrotic syndrome and hyperemesis in early pregnancy. Pertinent initial investigations revealed a severe acute kidney injury, a serum albumin of 19 g/L, a random protein creatinine ratio of 800 g/mol and microscopic haematuria. All immunological and infection serology testing including anti-glomerular basement membrane (anti-GBM; ELISA) were negative.

View Article and Find Full Text PDF

Management of immune-mediated glomerular diseases in the elderly.

Ren Fail

December 2024

S.C.D.U. Nefrologia, Dialisi e Trapianto, ARNAS Brotzu, Cagliari, Italy.

Article Synopsis
  • Managing immune-mediated kidney diseases in elderly patients (≥75 years) is challenging due to age-related health issues and comorbidities.
  • Current classification systems and treatment guidelines are insufficient for this age group, necessitating a more tailored approach.
  • Treatment often involves immunosuppressive therapies, but careful drug choice and dosage are essential to minimize side effects, requiring a collaborative and patient-centered management strategy.
View Article and Find Full Text PDF
Article Synopsis
  • Acute kidney injury during pregnancy is fairly common, but anti-GBM disease is a rare cause, as illustrated by a 30-year-old woman who experienced impaired kidney function during her pregnancy.
  • A kidney biopsy revealed she had crescentic glomerulonephritis due to anti-GBM antibodies, which prompted aggressive treatment including steroids and plasma exchange, leading to improvement in her kidney function.
  • Despite the successful treatment, the patient developed malaria later in pregnancy, resulting in complications that required an emergency cesarean section, but she ultimately delivered a healthy baby at 33 weeks.
View Article and Find Full Text PDF

Outcome of rituximab treatment in children with non-dialysis-dependent anti-GBM disease.

Pediatr Nephrol

February 2025

Department of Pediatrics, Dr. v. Hauner Children's Hospital, LMU University Hospital, LMU Munich, Munich, Germany.

Article Synopsis
  • Anti-GBM disease is a rare and serious condition characterized by the body producing antibodies that attack a specific type of collagen in the kidneys, leading to quick kidney failure if not treated.
  • Current treatment guidelines recommend using plasma exchanges and drugs like steroids and cyclophosphamide, but cyclophosphamide can have severe side effects, prompting the search for alternatives like rituximab and mycophenolate mofetil.
  • A study analyzing five adolescent patients treated with rituximab and mycophenolate mofetil found promising results, with 80% showing preserved or improved kidney function after treatment, suggesting these alternatives may be less toxic and effective.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!